The Venture Codex Logo

The Venture Codex

Overview

Investment firm focused on life sciences.

Deals · 12mo

3

Stage focus

Series A
Series B

Geographic focus

United States

Sector focus

—

Investment portfolio

7rounds
NAMEDATESIZE
Khartis Therapeutics
Aug 2026Led
$50 MSeries B
Infinimmune
Aug 2026Participated
$75 MSeries A
Kinaset Therapeutics
Jan 2026Led
$103 MSeries B
Idrx
Aug 2024Participated
$120 MSeries B
OnCusp Therapeutics
Jan 2024Participated
$100 MSeries A
Escient Pharmaceuticals
Nov 2022Led
$120 MSeries C
Idrx
Aug 2022Participated
$122 MSeries A
Khartis Therapeutics
Aug 2026Led
$50 MSeries B
Infinimmune
Aug 2026Participated
$75 MSeries A
Kinaset Therapeutics
Jan 2026Led
$103 MSeries B
Idrx
Aug 2024Participated
$120 MSeries B
OnCusp Therapeutics
Jan 2024Participated
$100 MSeries A
Escient Pharmaceuticals
Nov 2022Led
$120 MSeries C
Idrx
Aug 2022Participated
$122 MSeries A
7
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Forge Life Science Partners: 7 funding rounds are recorded in the selected participation categories.All available history.
Forge Life Science Partners: 7 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A03
Series B21
Series C+10

Monthly Deal Activity

Forge Life Science Partners: 7 deals are recorded across 51 months.All available history.
Forge Life Science Partners: 7 deals are recorded across 51 months. All available history
MonthDeals
Aug '221
Sep '220
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '241
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '241
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '261
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '262
Sep '260
Oct '260

Sector Breakdown

Forge Life Science Partners: Health & Life Sciences is the largest displayed sector by deal count (7 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Forge Life Science Partners: Health & Life Sciences is the largest displayed sector by deal count (7 deals). All available history
SectorDeals
Health & Life Sciences7
Consumer & Lifestyle3
AI & Machine Learning1

Deal Size Distribution

Forge Life Science Partners: 7 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Forge Life Science Partners: 7 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M0
$50M-$100M2
$100M-$250M5
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Forge Life Science Partners: United States has the largest recorded deal count among the displayed regions (7 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Forge Life Science Partners: United States has the largest recorded deal count among the displayed regions (7 deals). All available history
RegionDeals
United States7
Forge Life Science Partners: 20 co-investors are shown, with Nextech Invest sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Forge Life Science Partners: Led accounts for 43% and participating for 57% of round participation.All available history.
Forge Life Science Partners: Led accounts for 43% and participating for 57% of round participation. All available history
CategoryDeals (count)Share (%)
Led343%
Participating457%
Forge Life Science Partners: Single-lead accounts for 33% and co-led for 67% of lead dynamics.All available history.
Forge Life Science Partners: Single-lead accounts for 33% and co-led for 67% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead133%
Co-led267%

Team